Legal & General Group »

Silverback Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $154k 28k 5.48
2023-09-30 $106k 28k 3.78
2023-06-30 $167k 25k 6.70
2023-03-31 $420k 65k 6.51
2022-03-31 $6.0k 1.6k 3.65
2021-12-31 $11k 1.6k 6.70
2021-09-30 $37k 3.7k 9.97
2021-06-30 $32k 1.0k 30.68
2021-03-31 $57k 1.3k 43.58
2020-12-31 $1.0k 13 76.92